Literature DB >> 17823601

Interstitial cystitis and systemic autoimmune diseases.

Joop P van de Merwe1.   

Abstract

The cause of interstitial cystitis, a chronic disease that affects the bladder, is unknown. Autoantibodies, such as those against nuclear and bladder epithelium antigens, have been found in patients with interstitial cystitis, but these are likely to be secondary to the disease. No data support a direct causal role of autoimmune reactivity in the pathogenesis of interstitial cystitis. Indirect evidence, however, does support a possible autoimmune nature of interstitial cystitis, such as the strong female preponderance and the clinical association between interstitial cystitis and other known autoimmune diseases within patients and families. The strongest association occurs between interstitial cystitis and Sjögren's syndrome. Increasing evidence suggests a possible role of autoantibodies to the muscarinic M3 receptor in Sjögren's syndrome. The M3 receptor is also located on the detrusor muscle cells of the bladder and mediates cholinergic contraction of the urinary bladder and other smooth muscle tissues. Autoantibodies to the M3 receptor might be important in both the early noninflammatory and the late inflammatory features of interstitial cystitis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17823601     DOI: 10.1038/ncpuro0874

Source DB:  PubMed          Journal:  Nat Clin Pract Urol        ISSN: 1743-4270


  43 in total

Review 1.  Stem Cell Therapy for Interstitial Cystitis/Bladder Pain Syndrome.

Authors:  Aram Kim; Dong-Myung Shin; Myung-Soo Choo
Journal:  Curr Urol Rep       Date:  2016-01       Impact factor: 3.092

Review 2.  Sjögren's syndrome accompanied with interstitial cystitis: a case report and review of the literature.

Authors:  Dongfeng Liang; Jinshan Lu; Aitao Guo
Journal:  Clin Rheumatol       Date:  2014-01-07       Impact factor: 2.980

3.  Beyond neurons: Involvement of urothelial and glial cells in bladder function.

Authors:  Lori A Birder; Amanda S Wolf-Johnston; Manjul K Chib; Charles A Buffington; James R Roppolo; Ann T Hanna-Mitchell
Journal:  Neurourol Urodyn       Date:  2010       Impact factor: 2.696

4.  Kenalog Injection into Hunner's Lesions as a Treatment for Interstitial Cystitis/Bladder Pain Syndrome.

Authors:  Lauren Rittenberg; Darlene Morrissey; Dominique El-Khawand; Kristene Whitmore
Journal:  Curr Urol       Date:  2017-07-30

5.  Early termination of a trial of mycophenolate mofetil for treatment of interstitial cystitis/painful bladder syndrome: lessons learned.

Authors:  Claire C Yang; David A Burks; Kathleen J Propert; Robert D Mayer; Kenneth M Peters; J Curtis Nickel; Christopher K Payne; Mary P FitzGerald; Philip M Hanno; Toby C Chai; Karl J Kreder; Emily S Lukacz; Harris E Foster; Liyi Cen; J Richard Landis; John W Kusek; Leroy M Nyberg
Journal:  J Urol       Date:  2011-01-15       Impact factor: 7.450

Review 6.  Cystitis, co-morbid disorders and associated epithelial dysfunction.

Authors:  Lori A Birder; Ann T Hanna-Mitchell; Emeran Mayer; Charles A Buffington
Journal:  Neurourol Urodyn       Date:  2011-06       Impact factor: 2.696

Review 7.  Models of inflammation of the lower urinary tract.

Authors:  Dale E Bjorling; Zun-Yi Wang; Wade Bushman
Journal:  Neurourol Urodyn       Date:  2011-06       Impact factor: 2.696

Review 8.  Interstitial cystitis/bladder pain syndrome: The evolving landscape, animal models and future perspectives.

Authors:  Yoshiyuki Akiyama; Yi Luo; Philip M Hanno; Daichi Maeda; Yukio Homma
Journal:  Int J Urol       Date:  2020-04-04       Impact factor: 3.369

9.  Intravesical dimethyl sulfoxide inhibits acute and chronic bladder inflammation in transgenic experimental autoimmune cystitis models.

Authors:  Ronald Kim; Wujiang Liu; Xiaohong Chen; Karl J Kreder; Yi Luo
Journal:  J Biomed Biotechnol       Date:  2010-11-11

10.  RDP58 inhibits T cell-mediated bladder inflammation in an autoimmune cystitis model.

Authors:  Wujiang Liu; Barry R Deyoung; Xiaohong Chen; David P Evanoff; Yi Luo
Journal:  J Autoimmun       Date:  2007-12-26       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.